SOX9 and lung adenocarcinoma: First, we found that SOX9 was elevated in cisplatin-resistant lung adenocarcinoma A549 cells (GSE108214) and nasopharyngeal carcinoma 5-8F cells (GSE135083) through GEO dataset analysis.